← Back to Clinical Trials
Recruiting NCT07451340

NCT07451340 Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07451340
Status Recruiting
Phase
Sponsor Ankara University
Condition Healthy
Study Type OBSERVATIONAL
Enrollment 215 participants
Start Date 2026-03-26
Primary Completion 2027-03

Trial Parameters

Condition Healthy
Sponsor Ankara University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 215
Sex FEMALE
Min Age 21 Years
Max Age 65 Years
Start Date 2026-03-26
Completion 2027-03
Interventions
Validity and reliability study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Cervical cancer remains an important public health issue affecting women's health. Cervical cancer screening plays a key role in reducing morbidity and mortality through early detection. Women's decisions to participate in screening are influenced not only by knowledge, but also by psychosocial factors such as social norms, perceived threat, perceived benefits and barriers, and self-efficacy. The Cervical Cancer Screening Uptake Questionnaire (CCSTQ) is a multidimensional instrument designed to assess psychological and social determinants that may influence women's participation in cervical cancer screening. The aim of this study is to translate and culturally adapt the CCSTQ into Turkish and to evaluate its psychometric properties among Turkish women.

Eligibility Criteria

Inclusion Criteria: * Native Turkish speakers who can read and understand Turkish * Aged between 21 and 65 years * Able to communicate consciously and effectively * Previously and/or currently sexually active * Provide informed consent and agree to complete the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) * Voluntary female participants Exclusion Criteria: * History of total hysterectomy without cervical preservation * Previous diagnosis of cervical cancer * Severe mental illness or cognitive impairment * Inability to complete the CCSTQ

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology